AIDS Group To Pharma CEO: Lower Your Prices Or Lower Your Pay

March 21, 2014 9:45 PM

114 0

AIDS Group To Pharma CEO: Lower Your Prices Or Lower Your Pay

Outraged by the prices that Gilead Sciences charges for some of its medicines, an AIDS advocacy organization has succeeded in placing what is being called a unique resolution before the drug company’s shareholders. The proposal ties compensation for chief executive John Martin to wider access to the drug maker’s popular roster of HIV and hepatitis C treatments.

The shareholder resolution from the AIDS Healthcare Foundation, which has previously lambasted Gilead and other drug makers over their pricing, was proposed in response to the recently approved Sovaldi pill for hepatitis C. Gilead priced its medicine at $84,000 for a 12-week treatment, which works o...

Read more

To category page

Loading...